Compare Amphastar Pharmaceuticals Inc (AMPH) vs Direxion Daily Semiconductor Bull 3X Shares (SOXL) Price & Performance

AMPH trades at $18.72, down 1.58% with bearish technical signals despite oversold RSI readings. The company reported mixed Q1 2026 results with EPS of $0.42 missing estimates of $0.70, continuing a trend of recent earnings disappointments. Valuation metrics appear reasonable with P/E of 11.29 and P/B of 1.07, while profitability remains solid with 47.34% gross margins. Recent news includes a Zacks Strong Sell rating and ongoing securities law investigation.

The stock faces near-term headwinds from earnings misses and negative analyst sentiment, though current valuations provide some downside protection. Upside potential exists if the company can execute its strategic pivot to proprietary drugs and biosimilars while managing BAQSIMI discount pressures. Key risks include ongoing legal scrutiny and competitive pressures in the generic drug market.

SOXL trades at $192.26, down 0.1% on the day, with technical indicators signaling a bearish trend as moving averages and ADX point to selling pressure. Recent news highlights extreme volatility, including a 23% single-day drop on June 23, 2026, driven by sector-wide semiconductor sell-offs. The fund faces structural risks from its 3x leverage, which amplifies losses in choppy markets, as noted by Seeking Alpha on July 4, 2026.

The outlook remains high-risk due to leverage decay and semiconductor sector instability. Investment opportunities hinge on a broad AI-driven chip recovery, but risks include volatility decay, hedge fund selling (Goldman Sachs, July 6, 2026), and geopolitical tensions affecting oil markets (New York Post, July 8, 2026).